InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+3.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by UECKER DARRIN, Chief Technology Officer. Insider active across 1 company, notably Pulse Biosciences, INC.. Aggregated, 6 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €212k. History available since 12 June 2023. The latest transaction was filed on 16 September 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
25,000 shares@ US$4.00Common StockSEC:0001437749-25-029432:0
25,000 shares@ US$4.0026.2% of flowCommon StockSEC:0001437749-25-029104:0
15,000 shares@ US$16.400.012% mcap50.0% of flowCommon StockSEC:0001437749-25-020563:0
7,365 shares@ US$2.053.1% of flowCommon StockSEC:0001437749-23-019539:0
7,365 shares@ US$2.053.1% of flowCommon StockSEC:0001437749-23-017295:0
7,365 sharesCommon StockSEC:0001387131-22-006921:0
6 of 6 declarations
About UECKER DARRIN
Uecker Darrin is the Chief Technology Officer and Director at PULSE BIOSCIENCES, INC., an innovative company in the field of medical technologies. In his role, he oversees technological development and research initiatives. Darrin brings deep technical expertise, thus contributing to innovation and growth at PULSE BIOSCIENCES.
